- Home
- DOUG vs RPTX Comparison
DOUG vs RPTX Comparison
Compare DOUG & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOUG
- RPTX
- Stock Information
- Founded
- DOUG 1911
- RPTX 2016
- Country
- DOUG United States
- RPTX Canada
- Employees
- DOUG N/A
- RPTX N/A
- Industry
- DOUG Building operators
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- DOUG Real Estate
- RPTX Health Care
- Exchange
- DOUG Nasdaq
- RPTX Nasdaq
- Market Cap
- DOUG 146.0M
- RPTX 141.1M
- IPO Year
- DOUG N/A
- RPTX 2020
- Fundamental
- Price
- DOUG $1.88
- RPTX $1.46
- Analyst Decision
- DOUG
- RPTX Strong Buy
- Analyst Count
- DOUG 0
- RPTX 3
- Target Price
- DOUG N/A
- RPTX $7.00
- AVG Volume (30 Days)
- DOUG 1.1M
- RPTX 569.3K
- Earning Date
- DOUG 11-07-2024
- RPTX 11-07-2024
- Dividend Yield
- DOUG N/A
- RPTX N/A
- EPS Growth
- DOUG N/A
- RPTX N/A
- EPS
- DOUG N/A
- RPTX N/A
- Revenue
- DOUG $966,442,000.00
- RPTX $66,524,000.00
- Revenue This Year
- DOUG $5.28
- RPTX $13.22
- Revenue Next Year
- DOUG $16.40
- RPTX N/A
- P/E Ratio
- DOUG N/A
- RPTX N/A
- Revenue Growth
- DOUG 1.86
- RPTX 18.19
- 52 Week Low
- DOUG $1.00
- RPTX $1.47
- 52 Week High
- DOUG $3.16
- RPTX $8.49
- Technical
- Relative Strength Index (RSI)
- DOUG 39.80
- RPTX 30.68
- Support Level
- DOUG $2.23
- RPTX $2.97
- Resistance Level
- DOUG $2.47
- RPTX $4.07
- Average True Range (ATR)
- DOUG 0.20
- RPTX 0.34
- MACD
- DOUG -0.08
- RPTX -0.17
- Stochastic Oscillator
- DOUG 7.34
- RPTX 0.38
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.